Clive Seymour will be responsible for the management of life-science sales and marketing, as well as all associated customer service and support operations, in the Asia Pacific region
Bruker Daltonics announces that Clive Seymour has been appointed as the company's vice president for Asia Pacific, effective 1 March 2004.
Bruker Daltonics's business in Asia Pacific has grown rapidly in recent years, based on innovative, high-quality products, and a strong commitment to customer service and support.
Seymour will be responsible for the management of the company's life-science sales and marketing, as well as all associated customer service and support operations in the Asia Pacific region, including Bruker Daltonics organisations in Australia, China/HK, Singapore/South-East Asia (Malaysia, Thailand, Vietnam, Laos, Cambodia, Philippines, Indonesia) and Taiwan, in addition to distribution channels covering South Korea and New Zealand.
Bruker Daltonics KK is managed separately from its Yokohama, Japan headquarters.
Frank Laukien, president and CEO of Bruker Daltonics, commented: "We are very pleased to have Clive join our team to manage the further growth in this large and diverse region.
"Clive brings a wealth of experience from a decade of managing life-science businesses in the Asia Pacific region, and he has an excellent track record for sales growth and business expansion in developing markets.
From March 1997 to February 2004, Seymour was vice president region Asia Pacific at Biacore, also assuming the roles of head of life science research business unit (2000) and vice president corporate communications (2002).
Previously, from 1992 to 1997, he was European market area manager for Pharmacia Biotech Europe, and regional marketing and sales manager for Pharmacia Biotech Asia Pacific.
"I am delighted to be joining Bruker Daltonics at such an exciting time in the growth of life-science applications of mass spectrometry," commented Clive Seymour.
"Asia-Pacific offers enormous potential for life-science solutions providers, with research and pharmaceutical development of high priority in the region. "Bruker Daltonics has clearly demonstrated its commitment to innovation and customer support, and is delivering comprehensive applications-focused platforms to a number of fields, including expression proteomics, biomarker discovery, clinical proteomics and metabonomics.
"I am looking forward to joining this impressive organisation to further develop and expand its Asia-Pacific operations."
